RxDoctor Payments Data

Matthew Money, MD

Otolaryngology · Provo, UTNPI 1326115403

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Bsn Medical Inc at 25.4% of the total. Reporting peaked in 2023 at $316 and has fallen 77.8% since, to $70 in 2025. That places this record below the midpoint for otolaryngology clinicians in UT, where the typical reported total is $1,304.

$852in general payments, 2019–2025

Across 34 payments — averaging $25.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bsn Medical Inc$217
  • AbbVie$116
  • KCI USA, Inc.$101
  • Medline Industries LP$61
  • Triad Life Sciences Inc.$61
  • Smith+Nephew$51
  • plus $245 from 8 others

What the payments were for

  • Food & beverage$852100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$852 in reported general payments places this provider in the 40th percentile of 104 otolaryngology providers in Utah.

See all otolaryngology providers in Utah

Medicare billing

Part B allowed, 2024
$80,865
Medicare patients
143
Services billed
972

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Daptomycin15$2,944
Gentamicin Sulfate16$649
Mupirocin13$122

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Provo

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →